Andrew Emmett, Managing Director, Science & Regulatory Affairs, speaks about the important regulatory issues facing the industry, specifically PDUFA reauthorization, the FDA and regulation. Also, hear his programming highlights from the Achieving Regulatory Approval and Compliance Track at the upcoming 2012 BIO International Convention.
|
April 30, 2013
|
April 30, 2013
|
April 27, 2013
|
April 25, 2013
|
|
April 25, 2013
|
April 25, 2013
|
April 24, 2013
|
April 24, 2013
|